Oncogenic effects of PAFR ligands produced in tumours upon chemotherapy and radiotherapy (2017)
- Authors:
- USP affiliated authors: CHAMMAS, ROGER - FM ; NEGRO, SONIA JANCAR - ICB
- Unidades: FM; ICB
- DOI: 10.1038/nrc.2017.15
- Subjects: APOPTOSE; NEOPLASIAS; ONCOGENES; CÉLULAS CULTIVADAS DE TUMOR
- Language: Inglês
- Imprenta:
- Source:
- Título: Nature reviews cancer
- ISSN: 1474-175X
- Volume/Número/Paginação/Ano: v. 17, n. 4, 2017
- Este periódico é de assinatura
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: bronze
-
ABNT
CHAMMAS, Roger e ANDRADE, Luciana Nogueira de Sousa e JANCAR, Sonia. Oncogenic effects of PAFR ligands produced in tumours upon chemotherapy and radiotherapy. Nature reviews cancer. London: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://doi.org/10.1038/nrc.2017.15. Acesso em: 10 jan. 2026. , 2017 -
APA
Chammas, R., Andrade, L. N. de S., & Jancar, S. (2017). Oncogenic effects of PAFR ligands produced in tumours upon chemotherapy and radiotherapy. Nature reviews cancer. London: Faculdade de Medicina, Universidade de São Paulo. doi:10.1038/nrc.2017.15 -
NLM
Chammas R, Andrade LN de S, Jancar S. Oncogenic effects of PAFR ligands produced in tumours upon chemotherapy and radiotherapy [Internet]. Nature reviews cancer. 2017 ; 17( 4):[citado 2026 jan. 10 ] Available from: https://doi.org/10.1038/nrc.2017.15 -
Vancouver
Chammas R, Andrade LN de S, Jancar S. Oncogenic effects of PAFR ligands produced in tumours upon chemotherapy and radiotherapy [Internet]. Nature reviews cancer. 2017 ; 17( 4):[citado 2026 jan. 10 ] Available from: https://doi.org/10.1038/nrc.2017.15 - PAF receptor and tumor growth
- Effect of WEB2170 on B16F10 melanoma growth survival time and expression of galectin-3, CD34 and caspase-3
- Effect of WEB2170 in B16F10 melanoma growth, survival time and expression of galectin-3, CD34 and CASPASE-3
- Platelet-activating factor (PAF) receptor as a promising target for cancer cell repopulation after radiotherapy
- Combined effects of dacabarzine and R715, an antagonist of the bradykinin receptor subtype I, impaired melanoma associated angiogenesis
- Sialylation of beta1 integrins blocks cell adhesion to galectin-3 and protects cells against galectin-3-induced apoptosis
- Synthesis and preliminary assessment of 99m tc -HYNIC-Fab's (rituximab) for non-Hodgkin lymphoma diagnosis
- Guanosine promotes B16F10 melanoma cell differentiation through PKC–ERK 1/2 pathway
- O Instituto do Câncer do Estado de São Paulo, instituro especializado em Oncologia...[Prefácio]
- Introdução ao câncer
Informações sobre o DOI: 10.1038/nrc.2017.15 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
